J-Pharma Co., Ltd.

520A・Growth Market・Pharmaceuticals

Official website

J-Pharma Co., Ltd.

520A・Growth Market・Pharmaceuticals

Official website

J-Pharma Co., Ltd.520A

Reference Indicators

Market Cap

73¥100M

P/E (Forecast)

—

P/B

1.8x

Dividend Yield (Forecast)

0.00%

ROE

-60.7%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2026Mar 2026
SG&A Expenses	695
Operating Income	-3,710
Non-operating Income	1,110
Non-operating Expenses	36
Ordinary Income	-2,636
Extraordinary Income	184
Extraordinary Losses	13
Pre-tax Income	-2,465
Income Taxes	1
Net Income	-2,466
EBITDA	-3,708
ROA	-51.8%
ROE	-60.7%